116 related articles for article (PubMed ID: 22930520)
21. 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as a substrate of cytochrome P450 2D6: allosteric effects of NADPH-cytochrome P450 reductase.
Modi S; Gilham DE; Sutcliffe MJ; Lian LY; Primrose WU; Wolf CR; Roberts GC
Biochemistry; 1997 Apr; 36(15):4461-70. PubMed ID: 9109653
[TBL] [Abstract][Full Text] [Related]
22. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis of CYP2D6.31 variant: homology modeling suggests possible disruption of redox partner interaction by Arg440His substitution.
Allorge D; Bréant D; Harlow J; Chowdry J; Lo-Guidice JM; Chevalier D; Cauffiez C; Lhermitte M; Blaney FE; Tucker GT; Broly F; Ellis SW
Proteins; 2005 May; 59(2):339-46. PubMed ID: 15726636
[TBL] [Abstract][Full Text] [Related]
24. Cloning and characterization of the NADPH cytochrome P450 reductase gene (CPR) from Candida bombicola.
Van Bogaert IN; Develter D; Soetaert W; Vandamme EJ
FEMS Yeast Res; 2007 Sep; 7(6):922-8. PubMed ID: 17559413
[TBL] [Abstract][Full Text] [Related]
25. Change in enantioselectivity in bufuralol 1''-hydroxylation by the substitution of phenylalanine-120 by alanine in cytochrome P450 2D6.
Masuda K; Tamagake K; Okuda Y; Torigoe F; Tsuzuki D; Isobe T; Hichiya H; Hanioka N; Yamamoto S; Narimatsu S
Chirality; 2005 Jan; 17(1):37-43. PubMed ID: 15526337
[TBL] [Abstract][Full Text] [Related]
26. Functional expression in Bacillus subtilis of mammalian NADPH-cytochrome P450 oxidoreductase and its spore-display.
Yim SK; Jung HC; Yun CH; Pan JG
Protein Expr Purif; 2009 Jan; 63(1):5-11. PubMed ID: 18678259
[TBL] [Abstract][Full Text] [Related]
27. Expression, purification, and characterization of a catalytically active human cytochrome P450 1A2:rat NADPH-cytochrome P450 reductase fusion protein.
Parikh A; Guengerich FP
Protein Expr Purif; 1997 Apr; 9(3):346-54. PubMed ID: 9126606
[TBL] [Abstract][Full Text] [Related]
28. Formation of indigo by recombinant mammalian cytochrome P450.
Gillam EM; Aguinaldo AM; Notley LM; Kim D; Mundkowski RG; Volkov AA; Arnold FH; Soucek P; DeVoss JJ; Guengerich FP
Biochem Biophys Res Commun; 1999 Nov; 265(2):469-72. PubMed ID: 10558891
[TBL] [Abstract][Full Text] [Related]
29. Genetic polymorphism of cytochrome P450 2D6 determines oestrogen receptor activity of the major infertility drug clomiphene via its active metabolites.
Mürdter TE; Kerb R; Turpeinen M; Schroth W; Ganchev B; Böhmer GM; Igel S; Schaeffeler E; Zanger U; Brauch H; Schwab M
Hum Mol Genet; 2012 Mar; 21(5):1145-54. PubMed ID: 22108178
[TBL] [Abstract][Full Text] [Related]
30. Recombinant human cytochrome P450 1A2 and an N-terminal-truncated form: construction, purification, aggregation properties, and interactions with flavodoxin, ferredoxin, and NADPH-cytochrome P450 reductase.
Dong MS; Yamazaki H; Guo Z; Guengerich FP
Arch Biochem Biophys; 1996 Mar; 327(1):11-9. PubMed ID: 8615680
[TBL] [Abstract][Full Text] [Related]
31. Functional expression of mammalian NADPH-cytochrome P450 oxidoreductase on the cell surface of Escherichia coli.
Yim SK; Jung HC; Pan JG; Kang HS; Ahn T; Yun CH
Protein Expr Purif; 2006 Oct; 49(2):292-8. PubMed ID: 16829136
[TBL] [Abstract][Full Text] [Related]
32. Heterologous expression of human cytochromes P450 2D6 and CYP3A4 in Escherichia coli and their functional characterization.
Pan Y; Abd-Rashid BA; Ismail Z; Ismail R; Mak JW; Ong CE
Protein J; 2011 Dec; 30(8):581-91. PubMed ID: 22001938
[TBL] [Abstract][Full Text] [Related]
33. Interaction of terfenadine and its primary metabolites with cytochrome P450 2D6.
Jones BC; Hyland R; Ackland M; Tyman CA; Smith DA
Drug Metab Dispos; 1998 Sep; 26(9):875-82. PubMed ID: 9733666
[TBL] [Abstract][Full Text] [Related]
34. Subtoxic product levels limit the epoxidation capacity of recombinant E. coli by increasing microbial energy demands.
Kuhn D; Fritzsch FS; Zhang X; Wendisch VF; Blank LM; Bühler B; Schmid A
J Biotechnol; 2013 Jan; 163(2):194-203. PubMed ID: 22922011
[TBL] [Abstract][Full Text] [Related]
35. Analysis of NADPH supply during xylitol production by engineered Escherichia coli.
Chin JW; Khankal R; Monroe CA; Maranas CD; Cirino PC
Biotechnol Bioeng; 2009 Jan; 102(1):209-20. PubMed ID: 18698648
[TBL] [Abstract][Full Text] [Related]
36. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
Shaw PM; Hosea NA; Thompson DV; Lenius JM; Guengerich FP
Arch Biochem Biophys; 1997 Dec; 348(1):107-15. PubMed ID: 9390180
[TBL] [Abstract][Full Text] [Related]
37. Involvement of human cytochrome P450 2D6 in the bioactivation of acetaminophen.
Dong H; Haining RL; Thummel KE; Rettie AE; Nelson SD
Drug Metab Dispos; 2000 Dec; 28(12):1397-400. PubMed ID: 11095574
[TBL] [Abstract][Full Text] [Related]
38. Comparison of catalytical activity and stereoselectivity between the recombinant human cytochrome P450 2D6.1 and 2D6.10.
Kong LM; Qian MR; Hu HH; Xu SY; Yu LS; Jiang HD; Chen SQ; Zeng S
Pharmazie; 2012 May; 67(5):440-7. PubMed ID: 22764579
[TBL] [Abstract][Full Text] [Related]
39. Biotechnological synthesis of the designer drug metabolite 4'-hydroxymethyl-alpha-pyrrolidinohexanophenone in fission yeast heterologously expressing human cytochrome P450 2D6--a versatile alternative to multistep chemical synthesis.
Peters FT; Dragan CA; Kauffels A; Schwaninger AE; Zapp J; Bureik M; Maurer HH
J Anal Toxicol; 2009 May; 33(4):190-7. PubMed ID: 19470220
[TBL] [Abstract][Full Text] [Related]
40. Bacterial expression and purification of the Arabidopsis NADPH-cytochrome P450 reductase ATR2.
Hull AK; Celenza JL
Protein Expr Purif; 2000 Apr; 18(3):310-5. PubMed ID: 10733884
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
